Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
Journal of Crohn'S & Colitis|June 13, 2024
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative ColitisNeeraj Narula, Hasan Hamam, Jasmine Liu, et al.
Inflammatory Bowel Diseases|February 23, 2013
Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 studyLloyd Mayer, William M Pandak, Gil Y Melmed, et al.
Inflammatory Bowel Diseases|December 23, 2009
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitisJoel R Pekow, Jeremy T Hetzel, Jami A Rothe, et al.
United European Gastroenterology Journal|April 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY TrialsJean-Frédéric Colombel, Silvio Danese, Stefan Schreiber, et al.
Inflammatory Bowel Diseases|March 6, 2018
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction TherapyParita Patel, Andres Yarur, Sushila Dalal, et al.
Inflammatory Bowel Diseases|May 19, 2012
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel diseaseFrank Hoentjen, Margien L Seinen, Stephen B Hanauer, et al.
Gastrointestinal Endoscopy|January 9, 2018
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel diseaseNoa Krugliak Cleveland, Dezheng Huo, Farah Sadiq, et al.
Nutrition and Healthy Aging|April 28, 2017
A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activitySumit Bhattacharyya, Theresa Shumard, Hui Xie, et al.
Gastroenterology & Hepatology|November 15, 2023
MMX Mesalamine for Induction and Maintenance Therapy in Mild-to-Moderate Ulcerative ColitisStephen B Hanauer, Gary R Lichtenstein, Michael A Kamm, et al.
Inflammatory Bowel Diseases|January 9, 2007
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximabBruce E Sands, Richard Kozarek, Jack Spainhour, et al.
Pageof 22